Covidien plc (COV) Completes Separation of Pharmaceuticals Business
7/1/2013 9:49:44 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin “regular way” trading on the New York Stock Exchange today under the symbol "MNK."
Help employers find you! Check out all the jobs and post your resume.
comments powered by